This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Nov 16;224(9):1624-1625.

doi: 10.1093/infdis/jiab179.

Reply to Kenyon

Klaus Jansen¹, Regina Selb¹, Sebastian Banhart², Susanne Buder³, Dagmar Heuer²

Affiliations

Affiliations

¹ Unit HIV/AIDS, STI and Blood-borne Infections, Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
² Unit Sexually Transmitted Bacterial Pathogens, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.
³ German Reference Laboratory for Gonococci, Unit Sexually Transmitted Bacterial Infections, Department for Infectious Diseases, Robert Koch Institute, Berlin, Germany.

PMID: 33822079
DOI: 10.1093/infdis/jiab179

Comment

Reply to Kenyon

Klaus Jansen et al. J Infect Dis. 2021.

. 2021 Nov 16;224(9):1624-1625.

doi: 10.1093/infdis/jiab179.

Authors

Klaus Jansen¹, Regina Selb¹, Sebastian Banhart², Susanne Buder³, Dagmar Heuer²

Affiliations

¹ Unit HIV/AIDS, STI and Blood-borne Infections, Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
² Unit Sexually Transmitted Bacterial Pathogens, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.
³ German Reference Laboratory for Gonococci, Unit Sexually Transmitted Bacterial Infections, Department for Infectious Diseases, Robert Koch Institute, Berlin, Germany.

PMID: 33822079
DOI: 10.1093/infdis/jiab179

No abstract available

PubMed Disclaimer

Comment in

Dual Azithromycin/Ceftriaxone Therapy for Gonorrhea in PrEP Cohorts Results in Levels of Macrolide Consumption That Exceed Resistance Thresholds by up to 7-Fold.
Kenyon C. Kenyon C. J Infect Dis. 2021 Nov 16;224(9):1623-1624. doi: 10.1093/infdis/jiab178. J Infect Dis. 2021. PMID: 33822092 No abstract available.

Comment on

Dual Azithromycin/Ceftriaxone Therapy for Gonorrhea in PrEP Cohorts Results in Levels of Macrolide Consumption That Exceed Resistance Thresholds by up to 7-Fold.
Kenyon C. Kenyon C. J Infect Dis. 2021 Nov 16;224(9):1623-1624. doi: 10.1093/infdis/jiab178. J Infect Dis. 2021. PMID: 33822092 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations